Sameh Elfangary of AstraZeneca is chairman of new PHRMAG committee

Dubai: A new executive committee has taken charge at the Pharmaceutical Research and Manufacturers Association Gulf for the period 2025–27. This diverse and accomplished group of industry leaders is dedicated to fostering innovation, collaboration, and sustainable access to life-saving medicines across the Gulf region.
The new committee includes Sameh Elfangary, as Chairman and Cluster President at AstraZeneca GCC & Pakistan; Ashraf Mallak, Vice-Chairman and Managing Director GCC at MSD, among others.
Founded in 2005, the PHRMAG represents 29 biopharmaceutical research companies in the region. It collaborates with health authorities and healthcare systems to ease access to treatments while ensuring transparency and ethical conduct.
“The healthcare ecosystem in our region is undergoing fast-paced transformation, bringing novel mix of opportunities and challenges,” said Elfangary, the newly appointed Chairman.
Key achievements during the previous committee’s term include strengthening industry collaboration with key stakeholders such as the Emirates Drug Establishment (EDE) and the Department of Health Abu Dhabi.
PHRMAG’s working groups also made significant contributions during this term.